Early research (Phase 1)Ended earlyNCT06162299
What this trial is testing
A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002
Who this might be right for
Chronic Hepatitis B
Yisheng Biopharma (Singapore) Pte. Ltd. 16